AstraZeneca's coronavirus vaccine is looking especially promising for the elderly

AstraZeneca building. — (Image credit: Getty Images)

Another potential coronavirus vaccine is moving along, with especially good news for the elderly.

AstraZeneca announced Monday that its COVID-19 vaccine in development with the University of Oxford has produced a similar immune response in both younger and older adults. The vaccine also results in low adverse responses among older people, the pharmaceutical giant said. That's a standout response considering COVID-19 tends to be more severe in older patients.

Several dozen coronavirus vaccines are in the works around the globe, with AstraZeneca's one of many undergoing clinical testing. It's unclear when AstraZeneca will publish the results of its large ongoing trial that will help determine its vaccine's safety, but it is expected to be one of the first vaccine candidates to seek regulatory approval, Reuters reports. This vaccine is expected to protect people from the coronavirus for about a year.

Article continues below

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Explore More

Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.